Search for: "-TPK Doe, et al v. State of Ohio, et al"
Results 161 - 180
of 445
Sorted by Relevance
|
Sort by Date
14 Jul 2015, 6:41 am
Ries et al., the Court of Appeals reversed a defense verdict in favor of the physician finding that testimony from an expert was not scientifically reliable under Daubert v. [read post]
21 Jul 2007, 8:28 am
Advanced, et alEisenberg v. [read post]
4 Jan 2023, 10:41 am
Last week, the Ohio Supreme Court ruled in EMOI Services, L.L.C. v. [read post]
18 Apr 2016, 9:58 am
Amgen Inc., et al., No. 15-1039 (Does the notice requirement of the BPCIA create an effective six-month exclusivity post-FDA approval?) [read post]
1 Apr 2010, 4:20 pm
CARTER, et al., Plaintiffs, v. [read post]
28 Mar 2015, 5:50 am
., et al. wanted to erect an electronic sign on its property facing Rt. 480 for the advertising of both on and off premise businesses, public service announcements, and political commentary. [read post]
2 Nov 2009, 7:20 am
Abdullahi et al. [read post]
1 Feb 2016, 11:44 am
Holden et al. 2014-0791. [read post]
24 Jul 2015, 10:01 am
Skadden, Arps, Slate, Meagher & Flom LLP, et al., a case rich in ironic implications. [read post]
17 Mar 2015, 5:07 pm
See e.g., In re Uranium Antitrust Litigation, 480 F.Supp. 1138 (N.D.Ill.1979); see also Rashbaum, et al., “U.S. [read post]
3 May 2016, 1:42 am
Dialogue, 27 U.S. 1 (1829) United States v. [read post]
1 Apr 2016, 8:22 am
Amgen Inc., et al., No. 15-1039 (Does the notice requirement of the BPCIA create an effective six-month exclusivity post-FDA approval?) [read post]
25 Aug 2006, 8:52 am
Meese v. [read post]
18 May 2016, 8:19 am
Amgen Inc., et al., No. 15-1039 (Does the notice requirement of the BPCIA create an effective six-month exclusivity post-FDA approval?) [read post]
1 Oct 2014, 5:06 am
Maleng, 514 F.3d 915 (9th Cir. 2008); and Family Winemakers of California, et al. v. [read post]
29 Sep 2013, 9:01 pm
Northeast Ohio Harness et al, 36 Ohio App 3d 14 (1987). [read post]
4 Oct 2010, 12:36 pm
The case was Hollingsworth, et al., v. [read post]
17 Mar 2016, 2:45 am
Amgen Inc., et al., No. 15-1039 (Does the notice requirement of the BPCIA create an effective six-month exclusivity post-FDA approval?) [read post]
11 Nov 2007, 10:11 am
City of Columbus, 136 F.3d 1055, 1062 (6th Cir. 1998), we affirm. 07a0438p.06 Smith, et al. v. [read post]
3 May 2018, 7:45 am
Burd et al., 2017-0279. [read post]
